Updated:
Health Innovation Pitch
HIP is an opportunistic, healthcare-focused venture capital firm built with and for a community of seasoned investors. Its network includes non-institutional...
Health Innovation Pitch
HIP is an opportunistic, healthcare-focused venture capital firm built with and for a community of seasoned investors. Its network includes non-institutional investors such as angels, family offices, and physicians alongside institutional investors including VCs, health systems, and strategics, who collaborate on diligence and collective investment decisions in innovative healthcare startups. HIP provides a full lifecycle venture model with advisory, commercial, and exit support, and focuses exclusively on healthcare.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
What is Health Innovation Pitch's investment focus?
The firm concentrates exclusively on early-stage private equity and venture investments in digital health and healthcare technology. Its mandate covers seed through growth-stage companies developing software, diagnostics, and tech-enabled care models. The investment team prioritizes opportunities where regulatory complexity and clinical validation cycles reward specialist capital over generalist funding approaches.
What investment stages does Health Innovation Pitch target?
The firm targets early-stage companies, including startups and seed-stage opportunities, and can follow on into growth rounds. Recorded strategy tags indicate an active posture in co-investment, seed, and early-growth financing within the healthcare innovation domain.
Which sectors does Health Innovation Pitch avoid?
By design, the firm avoids sectors outside healthcare innovation. It does not invest in generalist enterprise software, consumer internet, fintech, or industrial technology unless a company's core value proposition is inextricably tied to healthcare delivery, clinical outcomes, or life sciences.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: